AcmA, which comprises 3 LysM motifs and determines noncovalent binding to the cell wall peptidoglycan. Both fused proteins, i.e. 6HisxCjaAx3LysM and 6HisxCjaDx3LysM, were able to bind to nontreated or TCA-pretreated L. salivarius cells. Conclusion: Our results documented that the LysMmediated binding system allows us to construct GEM particles that present 2 C. jejuni antigens.
teriosis in the EU was 220,209 in 2011, which represented an increase of 2.2% compared to 2010. The EU notification rate was 50.28 per 100,000 population in 2011. However, as reported by the European Food Safety Authority (EFSA), there is considerable underascertainment and underreporting of the incidence of human campylobacteriosis; the true number of disease cases may range between 2 million and 20 million per year. The principal reservoirs of Campylobacter spp. are the alimentary tracts of wild and domesticated birds and mammals. There are multiple pathways for human exposure to the pathogen, including food, untreated drinking water, and contact with surface water or animals. Among these sources, broiler meat is unquestionably the main source of human infections due to the high levels of consumption by people. The occurrence of Campylobacter in broiler flocks in the EU in 2011 was high but varied widely among countries, ranging from 0 to 92.0% [EFSA, 2011; EFSA and ECDC, 2013] . According to the scientific opinion of the EFSA Panel on Biological Hazards, the handling, preparation, and consumption of undercooked broiler meat may account for 20-30% of human cases of campylobacteriosis, and 50-80% of human cases may be attributed to the chicken reservoir as a whole. It is estimated that reducing the numbers of Campylobacter in poultry intestines by 3 log 10 units at the time of slaughter would reduce the public health risk by at least 90%. Reducing the numbers of Campylobacter on the carcasses by 1 log 10 unit would reduce the public health risk by between 50 and 90% [EFSA, 2011] . Thus, the transmission of Campylobacter from poultry to humans is a serious public health concern. The prevention of human infections requires control measures at all stages of the food chain, from agricultural production on the farm to the processing, manufacture, and preparation of foods in both commercial establishments and the domestic environment. However, the main challenge is to develop an effective strategy to reduce the level of poultry stock infections. Given that the currently available biosecurity interventions appear to have limited effectiveness or are difficult to sustain, the most efficient strategy to decrease the number of human Campylobacter infections may be to implement an immunoprophylactic method, i.e. the protective vaccination of chickens. While it is known that maternal antibodies protect young chickens against Campylobacter colonization, there is no commercial vaccine against Campylobacter available to date [Cawthraw and Newell, 2010; Sahin, et al., 2003] . Due to the enormous genetic diversity observed among C. jejuni/C. coli strains, vaccination with live attenuated Campylobacter strains or using killed, whole-cell Campylobacter appears to be ineffective. Additionally, an effective chicken vaccine should induce a rapid and strong immune response, yet due to the short life span of broiler chickens the birds should be immunized during the first week of life when the avian immune system is immature. A recent test of subunit vaccines that consisted of conserved Campylobacter antigens delivered by attenuated Salmonella strains, Eimeria or nanoparticles, generated promising results [Annamalai et al., 2013; Buckley et al., 2010; Clark et al., 2012; Layton et al., 2011; Łaniewski et al., 2012; Wyszyńska et al., 2004] . Several detailed reviews recapitulating recent approaches to control Campylobacter in poultry via vaccination have been published within the last 5 years [Curtiss et al., 2007; de Zoete et al., 2007; Jagusztyn-Krynicka et al., 2009; Lin, 2009] . Lactic acid bacteria (LAB), which constitute a very heterogeneous group of Gram-positive, nonsporulating, low-GC-content microorganisms that are ubiquitous in many nutrient-rich environments, represent an attractive alternative for vaccinations that employ attenuated bacterial pathogens because their use eliminates the potential risk of increased virulence in young or immunocompromised individuals. Moreover, the mucosal administration of rLAB strains stimulates both systemic and mucosal immune responses against foreign antigens while only inducing a low-level immune response against the carrier strains [Bahey- El-Din, 2012; Bermudez-Humaran et al., 2011; Pontes et al., 2011; Wells and Mercenier, 2008] . In addition to using live LAB cells, nonliving trichloroacetic acid (TCA)-pretreated LAB cells (GEM particles -Grampositive enhancer matrix) that are deprived of some surface components and intracellular content can also constitute a safe and efficient vaccine delivery vector for heterologous proteins [Audouy et al., 2007; Bosma et al., 2006; van Roosmalen et al., 2006] . There are 2 strategies used to present heterologous antigens on the surface of LAB cells. The first approach makes use of the C-termini of cell-anchoring proteins that contain the LPXTG recognition motif. This mechanism requires processing by a sortase for covalent anchoring of the protein to the cell wall peptidoglycan [Call and Klaenhammer, 2013; Schneewind and Missiakas, 2012] . The second approach is based on the protein anchor (PA) domain of some lactococcal proteins, such as AcmA. AcmA is the major autolysin of Lactococcus lactis that is required for cell separation and is responsible for cell lysis during the stationary phase of growth [Buist et al., 1997] . The autolysin contains 3 domains: the N-terminal signal sequence, an active site domain, and a C-terminal peptidoglycan-binding domain (PA). The PA comprises 3 LysM motifs, each with about 45 amino acids, separated by spacer sequences. After secretion, AcmA is directed to the cell wall and its C-terminus determines its noncovalent binding to the cell wall peptidoglycan [Buist et al., 2008] . It has been demonstrated that hybrid PA fusions exhibit similar properties [Bosma et al., 2006; Raha et al., 2005; Steen et al., 2003] . Also LysM domains of other Gram-positive bacteria bind heterologous proteins to the cell wall peptidoglycan [Hu et al., 2010; Turner et al., 2004; Xu et al., 2011] .
This work consists of an attempt to evaluate the possibility of using GEM particles of Lactobacillus salivarius as a binding platform for 2 conserved, immunodominant, extracytoplasmic Campylobacter proteins: CjaA (Cj0982c in the genome of C. jejuni NCTC11168) and CjaD (Cj0113 in the genome of C. jejuni NCTC11168). Both proteins have been intensively studied as chicken vaccine candidates [Buckley et al., 2010; Clark et al., 2012; Layton et al., 2011; Łaniewski et al., 2012; Wyszyńska et al., 2004] .
Materials and Methods
Bacterial Strains, Primers, Plasmids, Media, and Growth Conditions The bacterial strains, plasmids, and primers used in this study are listed in tables 1 and 2 . L. lactis IL1403 and L. salivarius IBB3154 were used in this study. The L. salivarius IBB3154 belongs to the Regional Strains and Plasmids Collection of the IBB PAS (Institute of Biochemistry and Biophysics, Polish Academy of Sciences). The L. lactis IL1403 strain was routinely cultured at 30 ° C in M17 broth (Oxoid) containing 0.5% (weight/volume) glucose (GM17). The L. salivarius strain was cultured in MRS liquid or MRS agar (solidified with 1.5% agar) medium (Difco Laboratories, Detroit, Mich., USA) at 37 ° C. The E. coli strain TG1 was used as a host for the construction of recombinant plasmids. The E. coli strain Rosetta (DE3) LysS was used to overexpress pUWM1320 and pUWM1292, and the E. coli strain BL21 (DE3) was used to overexpress pUWM1282 and pUWM1146 [Łaniewski et al., 2014] . C. jejuni and E. coli strains were grown under standard conditions [Łaniewski et al., 2014] unless otherwise indicated. When needed, media were supplemented with antibiotics at the following concentrations: 100 μg·ml − 1 ampicillin, 30 μg·ml − 1 kanamycin, and 20 μg·ml − 1 chloramphenicol, as well as Campylobacter Selective Supplement (Oxoid) and IPTG (3 mg·ml -1 ) in DMF (dimethylformamide).
General DNA Manipulations
Standard DNA manipulations were carried out as described earlier by Sambrook and Russel [2001] or according to the manufacturer's instructions (A&A Biotechnology, Poland). The chromosomal DNA of C. jejuni 81-176 and L. lactis used for PCR reactions were isolated using a commercial kit and protocol (A&A Biotechnology). PCR were performed with PrimeStar HS DNA Polymerase (TaKaRa) or HotStar HiFidelity Polymerase (Qiagen) under standard conditions. Synthetic oligonucleotide synthesis and DNA sequencing for cloning experiments were performed by Genomed S.A., Warsaw, Poland. DNA sequencing of the PCR product spanning the 16S rDNA gene was performed by the DNA Sequencing and Oligonucleotide Synthesis Service at IBB PAS in Warsaw, using the sequencer ABI377 (Applied Biosystems), and then the nucleotide sequences were analyzed using BLAST against the nucleotide database on the NCBI website.
Construction of Recombinant Plasmids for Recombinant Protein Overexpression
A CjaD expression vector was made as follows. The cjaD coding sequence (without the signal sequence, amino acids 1-18) was amplified from C. jejuni 81-176 chromosomal DNA with the primers Cj0148BamHI and Cj0148RXhoI and cloned into pGEM-T Easy (Promega, Madison, Wisc., USA). Thereafter, the resulting plasmid, i.e. pUWM1290, was digested with XhoI and BamHI restriction enzymes and a 0.5-kb DNA fragment was inserted into pET28a, generating plasmid pUWM1292. The construction of the CjaA expression vector (pUWM1146) has been described previously [Łaniewski et al., 2014] .
The CjaA-LysM (pUWM1320) and CjaD-LysM (pUWM1282) expression vectors were constructed via a 2-step PCR method. Briefly, the primers LysMF and LysMRXhoI were used to amplify the DNA region encoding the C-terminal portion of AcmA (amino acids 211-439) from the chromosome of L. lactis IL1403. CjaANheI-CjaALysM and Cj0148Nhe-Cj0148LysM were used to amplify the cjaA and cjaD genes, respectively, from the chromosome of C. jejuni 81-176. The CjaALysM and Cj0148LysM primers contained 5 ′ leader nucleotide sequences complementary to LysMF. Each PCR product was purified using a Gel-Out extraction kit (A&A Biotechnology). Next, a mixture of 2 purified products (in equal amounts) was used as a template in a single PCR reaction, using the primers CjaANheI-LysMF or Cj0148Nhe-LysMF to amplify cjaA-lysM and cjaD-lysM, respectively. The resulting PCR products were purified and cloned into pGEM-T Easy to generate pUWM1288 and pUWM1277, respectively. Finally, using XhoI and NheI restriction enzymes, the 1.5-kb DNA region encoding CjaALysM and the 1.1-kb DNA fragment encoding CjaDLysM were transferred into pET28b in the native orientation, generating pUWM1320 and pUWM1282, respectively. Correct construction of the plasmids was verified by sequencing. Protein production was confirmed by Western blot using a previously obtained rabbit polyclonal anti-rCjaD or anti-rCjaA serum [Łaniewski et al., 2012; Pawelec et al., 2000] . All recombinant plasmids encode proteins with a 6His tag fused to their N-terminus to allow purification by affinity chromatography.
Overexpression and Purification of CjaA, CjaD, CjaALysM, and CjaDLysM CjaDLysM and CjaA were overexpressed and purified from E. coli BL21 harboring pUWM1282 and pUWM1146, respectively. CjaD and CjaALysM were overexpressed and purified from E. coli Rosetta (DE3) LysS harboring pUWM1292 and pUWM1320, respectively. Expression of CjaD and CjaDLysM was induced with 0.5 m M IPTG at OD 600 nm of ∼ 0.6 from cells growing at 18 ° C. CjaA and CjaALysM were overexpressed by autoinduction as described by Studier [2005] . After 24 h, cultures were centrifuged and cell pellets were suspended in 50 m M sodium phosphate (pH 8.0), 300 m M NaCl, and 10 m M imidazole. Cells were disrupted by sonication. Subsequently, the cell lysates were centrifuged and the resulting supernatants were applied onto a HisTrap column (Novagen). The proteins were eluted with an imidazole gradient. Fractions containing CjaD, CjaA, CjaDLysM, or CjaALysM were pooled and loaded onto a PD-10 column (GE Healthcare) equilibrated with 50 m M sodium phosphate (pH 8.0) and 150 m M NaCl. Overexpression and all purification steps were monitored via SDS-PAGE.
SDS-PAGE and Western Blotting
SDS-PAGE and Western blotting procedures were done using standard techniques. Blots were developed with nitro blue tetrazolium chloride/5-bromo-4-chloro-3-indolyl phosphate (Sigma-Aldrich) as a substrate using previously obtained rabbit polyclonal anti-rCjaA or anti-rCjaD serum [Łaniewski et al., 2012; Pawelec et 
Preparation of Live Cells and GEM Particles for the Binding Assay
Live cells for the binding assay were prepared from 1-ml cultures ( L. salivarius IBB3154 and L. lactis IL1403) with an absorbance of about 1.0 at OD 600 nm . Cells were collected by centrifugation and washed once with a 0.5 volume of phosphate-buffered saline (PBS) (58 m M Na 2 HPO 4 , 2H 2 O, 17 m M Na 2 H 2 PO 4 , H 2 O, 68 m M NaCl, pH 7.2). GEM particles were obtained via chemical pretreatment with 10% TCA (0.6 M ). This method is commonly used for peptidoglycan purification from cell wall extracts. Briefly, bacterial cells from 1-ml cultures ( L. salivarius IBB3154 and L. lactis IL1403) with an absorbance of about 1.0 at OD 600 nm were collected by centrifugation and washed once with a 0.5 volume of PBS. Next, the washed cells were resuspended in 200 μl of a 10% TCA solution and boiled for 30 min [Bosma et al., 2006] . Then, the GEM particles were washed 3 times with PBS. For protein binding, the prepared live cells and GEM particles were resuspended in MRS mixed with 1,000 pmol of recombinant protein (CjaA, CjaD, CjaALysM, or CjaDLysM) and incubated 60 min. Binding of the proteins to live LAB cells or GEM particles was analyzed by immunofluorescence and Western blot assays.
Binding Assays by Immunofluorescence and Western Blot Analysis
For the immunofluorescence assay, L. salivarius IBB3154 and L. lactis IL1403 cells and GEM particles that were mixed with protein were washed 3 times with 1× PBS and then resuspended in 4% (weight/volume) paraformaldehyde and incubated for 10 min at room temperature. Next, cells were washed with 1× PBS and resuspended in PBS containing 3% bovine serum albumin. After 30 min of incubation, primary rabbit anti-rCjaA or anti-rCjaD antibodies were added at a dilution of 1: 100, followed by additional incubation for 60 min at room temperature. Then the cells were washed 3 times with 1× PBS and resuspended in PBS containing 1% Tween 20. The cells were washed 3 more times with 1× PBS and then incubated for 1 h at room temperature with 100 μl of PBS containing 3% bovine serum albumin and the secondary anti-rabbit antibody Alexa fluor A488 diluted 1: 100. Next, the cells were washed 3 times with 1× PBS and resuspended in 50 μl of PBS. A 10-μl aliquot of the suspension was spread onto a chamber slide precoated with poly-L -lysine. This was followed by mounting in an antifading agent (fluorescence mounting medium; Dako). Fluorescence was visualized using a Nikon A1R MP microscope.
For the Western blot assay, GEM particles made from L. salivarius or live cells of L. salivarius were incubated with recombinant proteins for 1 h under gentle agitation at 37 ° C. Subsequently, they were centrifuged and the supernatants were retained for analysis. Next, the cells with bound proteins were washed 3 times with PBS and then resuspended in PBS for analysis. The supernatant and the cells were mixed with 4× SDS loading-dye and boiled. The proteins derived from equal amounts of culture extracts were analyzed by Western blot using polyclonal anti-rCjaA or anti-rCjaD serum [Łaniewski et al., 2012; Pawelec et al., 2000] .
Results and Discussion

Characterization of L. salivarius Strains
The aim of this work was to generate an LAB surface display system for C. jejuni antigens. We used 2 LAB strains: L. lactis , the LAB model microorganism tested as a mucosal delivery vector for therapeutic proteins and vaccines, and L. salivarius. The Lactobacillus genus has served as a delivery vector of heterologous antigens for mucosal immunization, and the genus has added advantages over Lactoccocus: lactobacilli can persist longer than lactococci in the digestive tract and some strains have probiotic properties [Turner et al., 2004] . The L. salivarius IBB3154 strain was isolated from chicken stool samples on MRS agar medium. Macroscopic and microscopic (see online suppl. fig. S1 ; for all online suppl. material, see www.kager.com/doi/10.1159/ 000368780) observations suggested that this isolated strain belonged to the genus Lactobacillus. The strain grew as white colonies on MRS agar medium (online suppl. fig. S1A ) and formed short rods that could be clearly seen by phase contrast microscopy (online suppl. fig. S1B ). The morphological and microscopic observations were confirmed by molecular identification: amplification of an intergenic chromosomal DNA region between the 16S rDNA and 23S rDNA using the genusspecific primer pairs 16-1A and 23-1B [Tannock et al., 1999] . This approach generated 2 polymerase chain reaction (PCR) products of 500 and 700 bp (online suppl. fig. S2 ) which are characteristic of strains belonging to the genus Lactobacillus. This indicated that the strain belonged to the genus Lactobacillus. To identify the species of the IBB 3154 strain, the 16S rDNA gene was amplified using 343F and 1406 primers (online suppl. fig.  S3 ). A PCR product of the expected size, i.e. 1 kb, was generated in amounts sufficient for DNA sequencing using the same 2 primers. The nucleotide sequence of this 16S rDNA PCR product was analyzed using BLAST against the nucleotide database on the NCBI website. The analysis revealed the highest identity, i.e. 99%, to the nucleotide sequence of the 16S rDNA gene of L. salivarius IBB3154 (GeneBank CP002034.1), thus identifying the taxonomic position of the strain as L. salivarius IBB3154. Because this L. salivarius IBB3154 strain was isolated from a chicken's digestive track, we speculate that it is able to colonize the chicken intestine. Using live Lactobacillus might facilitate vaccination procedures and lower the cost of immunization. However, because the efficacy of immunization is often dependent on, among others factors, the amount of antigen deliv-ered, GEM particles might be more effective than live cells. Thus, in this work we evaluated the possibility of employing L. salivarius GEM particles as a platform to present C. jejuni antigens.
C. jejuni Antigens Bind to LAB Cells via the LysM-Mediated Surface Display System
A crucial factor that determines the efficacy of subunit vaccines is the selection of antigen(s). As many Campylobacter strains can colonize the chicken at one time and because of the enormous genetic diversity observed among Campylobacter isolates, the potential vaccine candidate protein should be conserved among different pathogen serotypes/genotypes to induce cross-protection. To evaluate the potential of L. salivarius GEM particles as a delivery vector for C. jejuni antigens, we chose 2 immunodominant proteins: CjaA (Cj0982c in the genome of C. jejuni NCTC11168) and CjaD (Cj0113 in the genome of C. jejuni NCTC11168). CjaD is a peptidoglycan-associated protein (PAL) anchored in the outer membrane [Godlewska et al., 2009] . CjaA is the cysteine-binding protein components of the ABC transport system [Muller et al., 2005; Wyszyńska et al., 2004 Wyszyńska et al., , 2008 . It participates in the in vivo colonization process as the expression levels of the cjaA gene increase when bacterial cultures are grown in media that is deficient in iron or on solid media [Holmes et al., 2005] . Additionally, CjaA is more abundant in the proteome of clinical Campylobacter isolates compared to the proteome of the laboratory strain, and it is recognized by chicken maternal antibodies [Cordwell et al., 2008; Shoaf-Sweeney et al., 2008] . We analyzed the LAB cell wall-binding ability of recombinant proteins containing C. jejuni antigens (CjaA or CjaD) that were fused with the PA binding domain of the L. lactis peptidoglycan hydrolase AcmA, which contains 3 lysine motifs (LysM). For this purpose, 2 recombinant plasmids expressing fused proteins were constructed ( fig. 1 a) . To facilitate purification of the recombinant proteins, the hybrid proteins also contained a 6His tag at their N-terminus. The fused proteins 6HisxCjaAx3LysM (hereinafter referred to as CjaALysM) and 6HisxCjaDx3LysM (hereinafter referred to as CjaDLysM) were produced using an Escherichia coli expression system and purified by affinity chromatography. Western blot analysis with specific rabbit anti-CjaA/ fig. S5 ). We also found that the CjaALysM present in the supernatant was subject to extensive degradation ( fig. 3 a, lane 4) . We concluded that the process is stimulated by the PA domain of the fused protein, as it is not correctly localized.
It is generally accepted that successful chicken immunization against Campylobacter colonization should consist of several protective antigens or their epitopes delivered by an appropriate vector. Thus we decided to determine whether GEM particles can be used as a platform to present both the CjaA and CjaD antigens together as a potential divalent vaccine. We suspected that CjaDLysM, having a stronger ability to bind to cell wall peptidoglycan than CjaALysM, might remove CjaALysM from the GEM surface. To analyze the problem, GEM particles were reacted with the 2 purified hybrid proteins mixed in equal amounts. After binding, GEM particles were collected by centrifugation and washed, and the binding efficiency was determined by SDS-PAGE and immunoblotting. The results are given in figure 4 . We found that although a noticeable amount of CjaALysM stayed in the supernatant, a significant amount of the fusion was also bound to the GEM surface. Thus we concluded that even though Samples were prepared by boiling in 4× SDS loading dye. Proteins were resolved by 12% SDS-PAGE, transferred onto nitrocellulose, and probed with antibodies. Lanes 1-3 contain equal amounts of GEM particles mixed with: 1 -fusion protein; 2 -protein without LysM, and 3 -control, no recombinant protein. Lanes 4-6 contain equal amounts of supernatant fractions obtained after removing GEM particles by centrifugation. GEM mixed with: 4 -fusion protein; 5 -protein without LysM; 6 -control, no recombinant protein, and M -protein molecular-weight marker. CjaDLysM has a higher binding efficiency than CjaALysM it does not block CjaALysM binding.
In conclusion, this study demonstrates the potential use of LAB GEM particles to deliver Campylobacter antigens. Our results clearly indicate that GEM can be used as delivery vehicles for more than one antigen, and GEM may represent a good mucosal delivery tool for future applications in different chicken diseases.
